Denali Therapeutics (FRA:4DN) Marketable Securities : €806.2 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Denali Therapeutics Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Denali Therapeutics's Marketable Securities for the quarter that ended in Mar. 2024 was €806.2 Mil.

Denali Therapeutics's annual Marketable Securities increased from Dec. 2021 (€506.2 Mil) to Dec. 2022 (€1,055.6 Mil) but then declined from Dec. 2022 (€1,055.6 Mil) to Dec. 2023 (€832.1 Mil).

Denali Therapeutics Marketable Securities Historical Data

The historical data trend for Denali Therapeutics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Denali Therapeutics Marketable Securities Chart

Denali Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

302.32

791.22

506.16

1,055.55

832.09

Denali Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															1,139.78	977.47	900.69	832.09	806.19

Denali Therapeutics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Denali Therapeutics (FRA:4DN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Denali Therapeutics Marketable Securities Related Terms

Thank you for viewing the detailed overview of Denali Therapeutics's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Denali Therapeutics (FRA:4DN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Denali Therapeutics Inc (FRA:4DN) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

DNLI:USA 4DN:Germany

Address

161 Oyster Point Boulevard, South San Francisco, CA, USA, 94080

Website

https://www.denalitherapeutics.com

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

Denali Therapeutics (FRA:4DN) Headlines

No Headlines